HMD

0.00%

1.7¢ heramed limited

Ann: Outstanding Results Achieved in Second JHC Clinical Trial, page-28

First 28 Last

Share
Profile

Follow
Gcshark

10 Posts.

12

05/05/22

20:02

Post #: 61235870
Share

Originally posted by dunnomuch: ↑

so that’s one of the HeraBEATs in the flesh so to speak. Interestingly enough, JHC is well behind the signups/devices ratio… turns out that they are taking a non-selective approach to pregnancies and who can use a HeraBEAT. So…. ALL pregnant women are being put into the HeraCARE platform from week 10 and due to work done for Mednax, JHC are recommending that the mum stays on HeraCARE for the 4th trimester (postpartum 10weeks). That means that from 10-20 weeks it’s license and no device, weeks 20-36+ are on the device and platform then back to platform only for another 10 weeks. All while paying the license charges and saving HEAPS of time for patients and medical staff.

Having just sat through a lunch with DG and Sivan from HMD and listening to some stuff from old mate Santo (who doesn’t get why Aussies put O at the end of names..) I’m left even more confused about HMD and it’s pretty ordinary share price performance. Biggest issue for JHC is availability of licenses, they are pretty keen to say the least. Some of the comments from them seem to be highly positive. Santo made some big calls too…

watching the platform in action is very cool. Listening to what the hospitals are saying is very encouraging. Understanding that the tech is being adapted and moulded by the hospitals across continents is amazing.
either it’s all very early days or something is SERIOUSLY missing in the whole scheme of things??? I guess REVENUE is missing and that’s what is sinking the share price. How much time till revenue kicks in?? Dunno… guess that’s why it’s SP is so low..

no idea… dunno…

Expand

This old mate Santo?

HMD Price at posting: 15.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

GRX

GreenX picks up prospective copper project in Germany

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

WGX

Westgold sets its sights on top five producer status through merger with Karora

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Is oil undervalued?

There are more pages in this discussion • 50 more messages in this thread...

First 28 Last

Add HMD (ASX) to my watchlist

(20min delay)
Last 1.7¢		Change 0.000(0.00%)		Mkt cap ! $10.76M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	50000	1.5¢

Sellers (Offers)

Price($)	Vol.	No.
1.7¢	432216	2

View Market Depth

No.	Vol.	Price($)
1	50000	0.015
1	142857	0.014
1	500000	0.013
2	327411	0.012
1	45480	0.011

Price($)	Vol.	No.
0.017	432216	2
0.020	213468	2
0.021	50000	1
0.022	150000	1
0.025	8565	1

Last trade - 16.12pm 02/08/2024 (20 minute delay)

HMD (ASX) Chart

Day chart unavailable

Ann: Outstanding Results Achieved in Second JHC Clinical Trial, page-28

Venture to sniff out high-grade REE targets at Jupiter project, WA

GreenX picks up prospective copper project in Germany

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Westgold sets its sights on top five producer status through merger with Karora

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Is oil undervalued?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Outstanding Results Achieved in Second JHC Clinical Trial, page-28

Top Stories

Venture to sniff out high-grade REE targets at Jupiter project, WA

GreenX picks up prospective copper project in Germany

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Westgold sets its sights on top five producer status through merger with Karora

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Is oil undervalued?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News